NOUVELLE THÉRAPIE POUR L'AMYLOSE LIÉE À LA TRANSTHYRÉTINE

• 收藏
• 分享

专利权人:

SOM INNOVATION BIOTECH S.L.

发明人:

申请号：

EP12778323.1

公开号：

EP2770988B1

申请日:

2012.10.23

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis. It is also provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis in combination therapy with another COMT inhibitor, a benzoxazole derivative, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, or epigallocatechin-3-gallate.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/